2,3 Prior research has shown mixed results for patients metabolic rebound, with some showing weight gain after stopping GLP-1s and others showing weight maintenance
These results havent been published in a peer-reviewed journal yet, but theyre the most up-to-date retatrutide weight-loss data available
These effects are generally not clinically significant for most medicines, but caution is advised with narrow therapeutic index drugs (e.g., warfarin, where INR monitoring may be appropriate)
WADA publishes Prohibited List 2024 29.09.2023 The new Prohibited List of the World Anti-Doping Agency (WADA) for 2024 has been published
A dietitian may suggest adopting a DASH diet or a Mediterranean diet, depending on your medical history and food preferences
Although obesity may increase the risk of psychiatric disorders, mental health conditions also contribute to the development or worsening of obesity through various mechanisms such as emotional eating and decreased motivation for physical activity [34, 35]